Source: Proceedings of the National Academy of Sciences USA. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUSSENBLATT, Robert B. et al. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proceedings of the National Academy of Sciences USA, v. 96, p. 7462-7466, 1999Tradução . . Disponível em: https://doi.org/10.1073/pnas.96.13.7462. Acesso em: 15 maio 2024.APA
Nussenblatt, R. B., Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Veldhuisen, P. V., et al. (1999). Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proceedings of the National Academy of Sciences USA, 96, 7462-7466. doi:10.1073/pnas.96.13.7462NLM
Nussenblatt RB, Fortin E, Schiffman R, Rizzo L, Smith J, Veldhuisen PV, Sran P, Yaffe A, Goldman CK, Waldmann TA, Whitcup SM. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial [Internet]. Proceedings of the National Academy of Sciences USA. 1999 ; 96 7462-7466.[citado 2024 maio 15 ] Available from: https://doi.org/10.1073/pnas.96.13.7462Vancouver
Nussenblatt RB, Fortin E, Schiffman R, Rizzo L, Smith J, Veldhuisen PV, Sran P, Yaffe A, Goldman CK, Waldmann TA, Whitcup SM. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial [Internet]. Proceedings of the National Academy of Sciences USA. 1999 ; 96 7462-7466.[citado 2024 maio 15 ] Available from: https://doi.org/10.1073/pnas.96.13.7462
